You are here: Industry Insights > Medigen

News List

NewsPoints AstraZeneca has higher efficacy with Medigen: study FirstWordPharma
December 06, 2021
Researchers running a trial in Taiwan, China have found that a combination of AstraZeneca's COVID-19 vaccine and the locally-developed Medigen shot is more effective than two doses of AstraZeneca, reported Taipei Times.
Medigen, BlueWillow collaborate to develop SARS-CoV-2 intranasal vaccine pharmaceutical-business-review
November 12, 2020
Medigen Vaccine Biologics (MVC) has collaborated with BlueWillow Biologics for the development of intranasal vaccine for SARS-CoV-2, the novel coronavirus responsible for Covid-19 disease.
Medigen, Dynavax COVID-19 Vaccine Receives Taiwan, China Government Subsidy americanpharmaceuticalreview
October 19, 2020
Medigen Vaccine Biologics and Dynavax Technologies announced that MVC has obtained a China's Taiwan, China government subsidy for successfully initiating a Phase 1 clinical trial in Taiwan, China.
Dynavax and Medigen partner to develop adjuvanted Covid-19 vaccine pharmaceutical-technology
July 27, 2020
US-based Dynavax Technologies has partnered with Taiwan, China-based Medigen Vaccine Biologics to develop an adjuvanted Covid-19 vaccine candidate.